Picture of Biosenic SA logo

BIOS Biosenic SA News Story

0.000.00%
be flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapValue Trap

Brief: Bone Therapeutics Q1 Cash Balance Of 10.42 Million Euros

May 4 (Reuters) - BONE THERAPEUTICS SA  BOTHE.BR :
    * APPOINTMENTS OF JEAN STÉPHENNE AS CHAIRMAN
    * CASH BURN FOR FULL YEAR OF 2018 IS EXPECTED TO BE IN RANGE
OF
EUR 15-16 MILLION
    * EXPECTS TO HAVE SUFFICIENT CASH TO CARRY OUT ITS
OBJECTIVES
UNTIL END Q3 2019
    * THE COMPANY ENDED THE FIRST QUARTER OF 2018 WITH A CASH
BALANCE
OF € 10.42 MILLION
    * PATIENT RECRUITMENT COMPLETED FOR THE PHASE IIA LUMBAR
SPINAL
FUSION STUDY WITH ALLOB
    * € 19.45 MILLION OF COMMITTED CAPITAL RAISED VIA PRIVATE
PLACEMENT OF CONVERTIBLE BONDS
    * PLANS TO REPORT FINAL RESULTS FROM ALLOB PHASE I/IIA
DELAYED-UNION STUDY IN MID-2018

Source text for Eikon:  ID:nGNE7qb0JZ 
Further company coverage:  BOTHE.BR 

 (Gdynia Newsroom)
 ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

Recent news on Biosenic SA

See all news